AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Ondansetron in Nigeria
5 products registered with NAFDAC — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Sam Ondansetron Orally Disintegrating Tablets_ Tablet | B4-9110 | Sam Pharmaceutical Limited | active | 26 May 2030 |
| Onsett 8 Tablet | B4-3108 | Interpharma Industries Limited | active | 28 Sept 2027 |
| Onsett Injection | B4-3106 | Interpharma Industries Limited | active | 28 Sept 2027 |
| Onsett 4 Tablet | B4-3107 | Interpharma Industries Limited | active | 28 Sept 2027 |
| Ondansetrone Injection Solution for injection/infusion | B4-3794 | Excel Charis Pharmaceutical Chemical Limited | active | 25 Aug 2026 |
Ondansetron — NAFDAC Registration Details
NAFDAC (Nigeria) has 5 registered products containing Ondansetron, of which 5 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Ondansetron registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.